1.47
                                            Schlusskurs vom Vortag:
              $1.55
            Offen:
              $1.53
            24-Stunden-Volumen:
                755.95K
            Relative Volume:
              0.15
            Marktkapitalisierung:
                $4.83M
            Einnahmen:
              $12.99M
            Nettoeinkommen (Verlust:
              $-23.72M
            KGV:
              -0.0151
            EPS:
                -97.2514
            Netto-Cashflow:
                $-23.28M
            1W Leistung:
              -2.00%
            1M Leistung:
              +2.80%
            6M Leistung:
                -85.31%
            1J Leistung:
              -99.20%
            Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
                  
                      Aptevo Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      206-838-0500
                    
                Adresse
                  
                      2401 4TH AVE., SEATTLE, WA
                    
                Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                APVO
                            
                             
                        Aptevo Therapeutics Inc 
                           | 
                    1.47 | 21.40M | 12.99M | -23.72M | -23.28M | -97.25 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy | 
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight | 
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Smart tools for monitoring Aptevo Therapeutics Inc.’s price action2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
How to escape a deep drawdown in Aptevo Therapeutics Inc.2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Statistical indicators supporting Aptevo Therapeutics Inc.’s strengthPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
How Aptevo Therapeutics Inc. (AP81) stock behaves under inflation pressure2025 Price Action Summary & AI Driven Price Predictions - newser.com
Can Aptevo Therapeutics Inc. stock attract ESG capital inflowsGlobal Markets & High Win Rate Trade Alerts - newser.com
What technical models suggest about Aptevo Therapeutics Inc.’s comebackJuly 2025 Summary & Precise Trade Entry Recommendations - newser.com
Aptevo Therapeutics Inc. stock chart pattern explained2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com
Combining machine learning predictions for Aptevo Therapeutics Inc.2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
How Aptevo Therapeutics Inc. stock reacts to oil prices2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
Why Aptevo Therapeutics Inc. stock remains on watchlistsWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Is Aptevo Therapeutics Inc. stock gaining market shareRisk Management & Expert Approved Momentum Trade Ideas - newser.com
Will Aptevo Therapeutics Inc. see short term momentumPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
Trend analysis for Aptevo Therapeutics Inc. this week2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Why Aptevo Therapeutics Inc. stock appeals to analystsWeekly Loss Report & Reliable Trade Execution Plans - newser.com
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Is Aptevo Therapeutics Inc. still worth holding after the dipWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-02 22:17:38 - newser.com
Is Aptevo Therapeutics Inc. (AP81) stock nearing a technical breakoutJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
How to integrate Aptevo Therapeutics Inc. into portfolio analysis toolsIndex Update & High Conviction Buy Zone Alerts - newser.com
Can Aptevo Therapeutics Inc. recover in the next quarterTake Profit & Safe Capital Growth Trade Ideas - newser.com
Why Aptevo Therapeutics Inc. stock remains a top recommendationDollar Strength & Consistent Return Investment Signals - newser.com
Can Aptevo Therapeutics Inc. stock hit analyst price targetsMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Measuring Aptevo Therapeutics Inc.’s beta against major indices2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):